Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of exogenous drug activation of chemical-induced signaling complexes expressed in engineered cells in vitro and in vivo

Methods of exogenous drug activation of chemical-induced signaling complexes expressed in engineered cells in vitro and in vivo

US Patent 12358970 · Granted Jul 15, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Homology directed repair compositions for the treatment of hemoglobinopathies2025
Coupling endonucleases with end-processing enzymes drives high efficiency gene d2025
Optimized mRNA encoding CAS9 for use in LNPs2025
Viral vectors and packaging cell lines2025
Homology directed repair compositions for the treatment of hemoglobinopathies2024
Rapamycin resistant cells2024
Coupling endonucleases with end-processing enzymes drives high efficiency gene d2024
Engraftable cell-based immunotherapy for long-term delivery of therapeutic prote2024
Methods for engineering allogeneic and immunosuppressive resistant T cell for im2024
Coupling endonucleases with end-processing enzymes drives high efficiency gene d2024
Methods of exogenous drug activation of chemical-induced signaling complexes exp2023
Method for treating autoimmune disease using CD4 T-cells with engineered stabili2023